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ABSTRACT 
 The objective of this study is to evaluate the association between persistence with 
mammography screening and stage at breast cancer diagnosis in elderly Appalachia-West 
Virginia women diagnosed with first incident breast cancer.  The study utilized West 
Virginia Cancer Registry-Medicare linked database to identify women age 70 and above 
diagnosed with first incident breast cancer in 2007.  Persistence to mammography 
screening was defined as having had at least three mammography screenings before breast 
cancer diagnosis.  A multiple logistic regression was conducted to assess the association 
between persistence with mammography screening and stage at breast cancer diagnosis in 
these women.  Of the 221 elderly Appalachia-West Virginia women included in the 
analysis, 113 women (51.1%) were persistent to mammography screening before their 
diagnosis with breast cancer.  In a multiple logistic regression after adjusting for all the 
variables, as compared to elderly women who were not persistent with mammography 
screening, women who were persistent with mammography screening were significantly 
more likely to be diagnosed with early stage breast cancer (adjusted odds ratio=4.25, 95% 
confidence interval=1.96-9.19).  Persistence with mammography screening is significantly 
associated with earlier stages of breast cancer in the rural and underserved Appalachia-
West Virginia women.  The study findings suggest targeting interventions to encourage 
regular mammography in these women for whom there are no clear guidelines. 
 
Keywords: Persistence, Mammography Screening, West Virginia Cancer Registry, 
Medicare 
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INTRODUCTION 
Breast Cancer and Mammography Screening in Appalachia-West Virginia 
West Virginia (WV), the only state that lies entirely in Appalachia, is largely a rural and 
medically underserved region in the United States (US) characterized by high poverty rates, low 
level of education, aging population, high rates of chronic diseases, and poor health behaviors 
(Kaiser State Health Facts, 2008; Kaiser State Health Facts, 2009; United States Census Bureau, 
2010; United States Census Bureau, 2010).  WV is reported to have higher rates of advanced and 
unstaged breast cancer (BC) (United States Cancer Statistics, 2010; United States Cancer 
Statistics, 2012; Lengerich, Chase, Beiler, & Darnell, 2006; SEER State Cancer Profiles, 2010; 
Wingo, Tucker, & Jamison, 2007), which has been attributed to lower mammography screening 
rates in women in this state (Khanna, Bhanegaonkar, Colsher, Madhavan, & Halverson, 2009; 
Lengerich et al., 2006; SEER State Cancer Profiles, 2010).  Also, in elderly WV women, BC 
accounted for 21.9% of all the incident cancer cases for year 2004 (United States Cancer 
Statistics, 2008) and 11.4% of all the cancer deaths for year 2007 (CDC National Center for 
Health Statistics, 2015).  The authors of several studies and reports have argued that low 
mammography screening rates and less access to health services in these vulnerable WV women 
may be one of the significant factors contributing to this higher BC-related mortality (Hall, 
Uhler, Coughlin, & Miller, 2002; SEER State Cancer Profiles, 2010). 
Persistence with Mammography Screening and Stage at Breast Cancer Diagnosis 
Persistence with mammography screening defined as having had at least three 
mammography screenings in five years is associated with presentation of BC at earlier stages in 
elderly women (Vyas, Madhavan, & Sambamoorthi, 2014).  In addition, regular use of 
mammography screening helps detect tumor when its size is small and potentially treatable and 
patients may have less aggressive treatments (Humphrey, Helfand, Chan, & Woolf, 2002).  
Previous studies which reported the beneficial effects of mammography screening on early stage 
of BC representation using SEER-Medicare data captured use of mammography screening in two 
years before diagnosis which may not necessarily take into account past screening behavior and 
intervals between recent and prior screenings (McCarthy et al., 2000; Randolph, Goodwin, 
Mahnken, & Freeman, 2002).  These studies are also limited with the fact that they have either 
utilized data from fewer cancer registries (McCarthy et al., 2000; Randolph et al., 2002).  
Previous studies which analyzed persistent mammography screening behavior in five years prior 
to BC diagnosis in using SEER-Medicare data have been conducted among women age 80 and 
above (Badgwell et al., 2008) and could not be generalized to the rural elderly women in 
Appalachia-WV due to its distinct demographic and socio-economic characteristics.  In addition, 
the SEER-Medicare data reflects a population more likely to be residing in urban setting 
(Warren, Klabunde, Schrag, Bach, & Riley, 2002), due to which no information is available 
about the beneficial effects of mammography screening on stage at BC diagnosis among elderly 
Medicare beneficiaries from rural and medically underserved regions, and from non-SEER 
Medicare states.  Moreover, these previous published studies except the one by Vyas et al. 
(2014) did not utilize any model or technique to differentiate between screening and diagnostic 
mammograms which is one of the major issues with Medicare claims data.  Nevertheless, the 
Vyas et al. (2014) study focused on the entire SEER population with no information on rural and 
medically underserved population (Vyas et al., 2014).  A recently published study has 
recommended a three-step algorithm with high sensitivity of 99.7% and positive predictive value 
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of 97.4% to identify screening mammograms from the Medicare claims data (Fenton et al., 
2014). 
The purpose of the study is to determine the association between persistence with 
mammography screening and stage at BC diagnosis in Appalachia-WV Medicare fee-for-service 
(FFS) women beneficiaries diagnosed with a first incident BC utilizing a WV Cancer Registry-
Medicare linked dataset built to study cancer disparities in the state.   
 
METHODS 
Data Source 
West Virginia Cancer Registry-Medicare-Area Resource File linked dataset.  Established 
by the WV Department of Health and Human Resources in 1993, the West Virginia Cancer 
Registry (WVCR) is a state-level cancer registry that provides information on cancer incidence 
and mortality in WV (West Virginia Department of Health and Human Resources, 2012).  The 
registry collects and provides data on the primary site of cancer, tumor grade, date and stage of 
diagnosis, date and cause of mortality, and demographics such as age, gender, race, and also zip 
code information (for location of residence).  The de-identified linked WVCR-Medicare dataset 
was established at West Virginia University (WVU) in full compliance with the WVU 
Institutional Review Board and HIPPA requirements (Nadpara & Madhavan, 2012).  The details 
of the WVCR-Medicare linkage and dataset are described elsewhere (Nadpara & Madhavan, 
2012).  Through the state and county Federal Information Processing Standards codes for each 
beneficiary, the Area Resource File (ARF) was linked to the WVCR-Medicare dataset to identify 
the census level information on healthcare facilities and socioeconomic characteristics of the 
region’s population. 
Study Design and Study Cohort 
 This retrospective study comprised of women age 70 and older with the first primary 
incident BC diagnosed in 2007.  As persistence with mammography screening during the period 
of five years before BC diagnosis was to be evaluated, women age 70 and above who were 
continuously enrolled in Medicare parts A and B for at least five years before BC diagnosis, and 
who were not enrolled in health maintenance organizations (HMOs) at any time during the study 
period were included in the study.  Women with a previous cancer, unknown/missing stage, and 
who were diagnosed through death certificate or autopsy were excluded from the study.  Out of a 
total of 661 women diagnosed with BC in 2007, the following women were excluded: 168 
women who were younger than 70 years at diagnosis, 99 women with previous cancer, seven 
women who were diagnosed during death or autopsy, 56 women for whom BC stage information 
was unknown/missing, 32 women who were not continuously enrolled in Medicare parts A and 
B, and 72 women who had been members of a HMO in the five years prior to diagnosis.  From 
the remaining 227 women, only 6 women (2.6%) belonged to ‘other’ race which resulted in very 
small cell-size for stage at diagnosis categories, and hence were removed from the analyses.  
Finally, a total of 221 non-Hispanic white Appalachia-WV women were included in the study. 
Measures 
Dependent Variable-Stage at diagnosis:  The SEER summary staging system which is a 
combination of the most accurate clinical and pathological documentation of the extent of 
disease (Young, Roffers, Ries, Fritz, & Hurlbut, 2001) and which uses all the data in the medical 
record was utilized to define BC stage at diagnosis.  It was categorized into ‘early stage’ 
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consisting of carcinoma in situ and localized cancers, and ‘late stage’ consisting of regional and 
distant cancers. 
Key Independent Variable-Persistence with mammography screening:  This study 
utilized a three-step algorithm with sensitivity of 99.7% and positive predictive value of 97.4% 
of a screening designation to identify screening mammograms from the Medicare claims files 
(Fenton et al., 2014).  As per this algorithm, firstly all the mammograms, irrespective of whether 
they were for screening or diagnostic purpose, were identified from the Medicare claims files for 
each woman in five years before her BC diagnosis.  If a woman had a mammogram within nine 
months of another mammogram then those mammograms were removed.  If a woman did not 
have a mammogram within nine months then the Healthcare Common Procedure Coding System 
(HCPCS) code for those mammograms was determined.  If the HCPCS code for a mammogram 
was for ‘screening’ purpose then those mammograms were considered to be screening 
mammograms.  If the HCPCS code for a mammogram was for ‘diagnostic’ purpose then the BC-
related symptom within 349 days prior to the diagnostic mammogram were identified.  If a 
women had a BC-related symptom beyond 350 days or more prior to a diagnostic mammogram 
then those mammograms were considered to be screening mammograms.  All the mammograms 
with HCPCS code for ‘screening’ purpose and those for which BC-related symptom was beyond 
350 days or more were considered to be ‘actual’ screening mammograms and were utilized to 
determine persistence with mammography screening for each woman in the study.  
As defined in a recently published study, a woman was considered persistent with 
mammography screening if she had at least three screening mammograms in the five years prior 
to her BC diagnosis (Vyas et al., 2014).  Hence, based on total number of screening 
mammograms a woman had in the five years prior to her BC diagnosis, the study cohort was 
dichotomized into non-persistent users (with 0-2 screening mammograms) and persistent users 
(with three or more screening mammograms).  
Other Independent Variables:  The covariates consisted of age at BC diagnosis (70-74, 
75-79, 80 and older); census tract median household income (<$30,000; ≥$30,000); and census 
tract percentage of people age ≥ 25 years with at least 4 years of college education (<15%, 
≥15%); comorbidity scores (0 (no comorbidity), 1, ≥2); the number of primary care physicians 
(PCP) visits in the five years before BC diagnosis categorized into two groups (0-23, ≥24) based 
on its median value; location of residence (metro, urban, rural) and the number of hospitals 
offering BC screening/mammography services in the area of residence categorized into 0, 1, ≥2.  
Comorbidity scores were calculated from the co-occurring chronic conditions obtained from the 
Medicare files. 
Statistical Analyses        
To determine significant differences between persistence with mammography screening 
groups across all the independent variables, chi-square statistics were conducted.  In addition, 
significant differences between early and late stage BC across all the independent variables were 
analyzed.  The percentage of women by stage of disease according to persistence with 
mammography screening was also determined.  Logistic regression was conducted to determine 
the association between persistence with mammography screening and an early BC stage, after 
controlling for all the independent variables.  “Late stage breast cancer” was used as the 
reference group for the dependent variable.  From the logistic regression, the parameter estimates 
were transformed into odds ratios and their corresponding 95% confidence intervals were 
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determined and the findings that were significant with p-values less than or equal to 0.05 levels 
are discussed.  All analyses were conducted using statistical analysis systems software SAS 9.4 
(SAS® version 9.4, SAS Institute Inc., Cary, NC, USA). 
 
RESULTS 
Description of the Study Cohort by Persistence with Mammography Screening 
The left columns of Table 1 characterize the study cohort of 221 elderly Appalachia-WV 
women diagnosed with first primary incident BC in 2007.  A majority of the study cohort was 
age 80 and above (40%), resided in metro areas (54%), had household income below $30,000 
(51%), resided in areas with higher education (54%), had no comorbidity (48%) and had higher 
PCP visits in five years before BC diagnosis.  The right side column of Table 1 describes the 
results from the chi-square statistics for differences in persistence with mammography screening 
across all the independent variables.  A majority of elderly Appalachia-WV women (51%) were 
persistent to mammography screening while 49% of the women were not persistent to 
mammography screening.  Among all women age 70-79 years, a majority of them were 
persistent with mammography screening, while older women age 80 and older were less likely to 
be persistent with mammography screening.  All the other independent variables were not 
significant in the chi-square analyses at the < 0.05% level.   
To identify if persistence with mammography screening would differ between women 
with ‘known’ and ‘unknown’ stage BC, analyses was conducted after retaining women with 
‘unknown’ BC stage.  It was found that there was no significant differences in persistence with 
mammography screening in women with ‘known’ and ‘unknown’ stage BC (data not shown). 
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Table 1 
West Virginia Medicare FFS Beneficiaries with Incident Breast Cancer  
By Persistence with Mammography Screening 
West Virginia Cancer Registry-Medicare 2007 Cases 
Variables 
Total % 
Persistent 
Users§ % 
Non- 
Persistent 
Users % Sig 
  
221 
 
113 51.1 108 48.9 
 Stage at Diagnosis       *** 
 Early Stage 175 79.2 100 88.5 75 69.4  
 Late Stage 46 20.8 13 11.5 33 30.6  
Age at Diagnosis 
      
* 
 
70-74 72 32.6 38 33.6 34 31.5 
 
 
75-79 61 27.6 38 33.6 23 21.3 
 
 
≥80 88 39.8 37 32.7 51 47.2 
 Location of Residence 
       
 
Metro 120 54.3 55 48.7 65 60.2 
  Urban 63 28.5 40 35.4 23 21.3  
 
Rural 38 17.2 18 15.9 20 18.5 
 Census Tract Household Income 
     
 
<$30,000 113 51.1 60 53.1 53 49.1 
 
 
≥$30,000 108 48.9 53 46.9 55 50.9 
 Census Tract Education 
      
 
<15% 101 45.7 57 50.4 44 40.7 
 
 
≥15% 120 54.3 56 49.6 64 59.3 
 Comorbidity 
       
 
0 105 47.5 60 53.1 45 41.7 
 
 
1 63 28.5 30 26.5 33 30.6 
 
 
≥2 53 24.0 23 20.4 30 27.8 
 PCP visits 
     
  
 
0-23 109 49.3 55 48.7 54 50.0 
 
 
≥24 112 50.7 58 51.3 54 50.0 
 Total BC Screening Centers 
      
 
0 21 9.5 9 8.0 12 11.1 
 
 
1 102 46.2 53 46.9 49 45.4 
 
 
≥2 98 44.3 51 45.1 47 43.5 
          
Note: FFS, Fee For Service; PCP, Primary Care Physicians; BC, Breast Cancer; Sig, Significance.  
§Persistent users of screening mammograms are those women who have had at least three screening mammograms 
in the five years prior to their breast cancer diagnosis. 
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Asterisks represent statistically significant group differences based on χ2 tests by persistence with mammography 
screening  
***P<0.001; **001<=P<.01 
 
Description of the Study Cohort by Stage at Breast Cancer Diagnosis 
Table 2 describes the results from the chi-square statistics for differences in stage at BC 
diagnosis across all the independent variables.  Among all the persistent users of mammography 
screening, a majority (89%) were diagnosed at an early stage BC.  All the other independent 
variables were not significant in the chi-square analyses at the < 0.05% level. 
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Table 2 
West Virginia Medicare FFS Beneficiaries with Incident Breast Cancer 
By Stage at Diagnosis 
West Virginia Cancer Registry-Medicare 2007 Cases 
 Variables   Early Stage % Late Stage % Sig 
      175 79.2 46 20.8   
Persistence with 
Mammography Screening       *** 
 Persistent Users   100 57.1 13 28.3  
 Non-Persistent Users   75 42.9 33 71.7  
Age at Diagnosis   
     
 
70-74   55 31.4 17 37.0 
 
 
75-79   46 26.3 15 32.6 
 
 
≥80   74 42.3 14 30.4 
 Location of Residence   
     
 
Metro   96 54.9 24 52.2 
  Urban   51 29.1 12 26.1  
 
Rural   28 16.0 10 21.7 
 Census Tract Household 
Income  
     
 
<$30,000   88 50.3 25 54.3 
 
 
≥$30,000   87 49.7 21 19.4 
 Census Tract Education   
     
 
<15%   75 74.3 26 25.7 
 
 
≥15%   100 88.3 20 47.8 
 Comorbidity   
     
 
0   86 49.1 19 41.3 
 
 
1   47 26.9 16 34.8 
 
 
≥2   42 24.0 11 23.9 
 PCP visits   
     
 
0-23   84 48.0 25 54.3 
 
 
≥24   91 52.0 21 45.7 
 Total BC Screening Centers   
   
  
 
0   18 10.3 3 6.5 
 
 
1   74 42.3 28 60.9 
 
 
≥2   83 47.4 15 32.6 
          
Note: FFS, Fee For Service; PCP, Primary Care Physicians; BC, Breast Cancer; Sig, Significance.  
Asterisks represent statistically significant group differences based on χ2 tests by stage at diagnosis  
***P<0.001 
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Stage at Breast Cancer Diagnosis by Persistence with Mammography Screening 
Figure 1 describes disease stage by persistence with mammography screening.  Among 
women who were persistent with mammography screening, an overwhelming 89% of them were 
diagnosed with an early stage disease.  Among women who were not persistent with 
mammography screening, 69% were diagnosed with an early stage disease. 
 
 
Figure 1:  Stage at Breast Cancer Diagnosis by Persistence with Mammography Screening Among West Virginia 
Medicare Fee-for-Service Beneficiaries with Incident Breast Cancer – 2007 Cases 
 
Association between Persistence with Mammography Screening and Stage at Breast Cancer 
Diagnosis 
Table 3 describes the results from the multiple logistic regression.  Appalachia-WV 
women who were persistent with mammography screening were four times more likely of being 
diagnosed at an early stage BC (Adjusted odds ratio (AOR) = 4.25, 95% confidence interval (CI) 
= 1.96-9.19) as compared to elderly women who were not persistent with mammography 
screening.  No other factors significantly affected the probability of being diagnosed at an early 
stage except for persistence with mammography screening.  
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Table 3 
Adjusted Odds Ratios and 95% Confidence Intervals from Logistic Regression  
on Early Stage at Breast Cancer Diagnosis 
For Persistence with Mammography Screening 
West Virginia Cancer Registry-Medicare 2007 Cases 
Variables  Early Breast Cancer Stage 
    AOR 95% CI Sig 
Persistence with Mammography Screening  
 
Persistent Users 4.25 [1.96 , 9.19] *** 
 
Non-Persistent Users 1 
 
 
Age at Diagnosis 
  
 
 
70-74 1 
 
 
 
75-79 0.75 [0.31 , 1.80]  
 
80,+ 1.69 [0.71 , 4.00]  
Location of Residence 
  
 
 
Metro 1 
 
 
 Urban 1.36 [0.53 , 3.50]  
 
Rural 1.29 [0.37 , 4.53]  
Census Tract Household Income  
 
<$30,000 1 
 
 
 
≥$30,000 1.03 [0.40 , 2.65]  
Census Tract Education 
  
 
 
<15% 1 
 
 
 
≥15% 2.24 [0.87 , 5.76]  
Comorbidity 
  
 
 
0 1 
 
 
 
1 0.72 [0.31 , 1.69]  
 
≥2 1.01 [0.39 , 2.59]  
PCP visits 
  
 
 
0-23 1   
 
≥24 1.15 [0.54 , 2.45]  
Total BC Screening Centers 
  
 
 
0 1 
 
 
 
1 0.26 [0.06 , 1.11]  
 
≥2 0.48 [0.10 , 2.30]  
     
Note: PCP, Primary Care Physicians, BC, Breast Cancer; AOR, Adjusted Odds Ratio; CI. Confidence Interval.  
"Late stage at breast cancer diagnosis" is the reference group for the dependent variable.  1 represents the reference 
groups within each independent variable.  Asterisks represent statistically significant group differences compared 
with the reference group 
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***P<0.001 
 
DISCUSSION 
To our knowledge, this is the first study which assessed the effect of persistence with 
mammography screening on stage at BC diagnosis in elderly women from a rural and medically 
underserved state such as WV, after accurately identifying screening mammograms from the 
Medicare claims data using a recently published algorithm.  In the absence of data on persistence 
with mammography screening from a rural setting and from non-SEER-Medicare states, this 
study fills a significant literature gap related to the important issue of mammography screening 
among elderly, rural, and underserved women of Appalachia-WV.   
Nearly half of elderly Appalachia-WV women diagnosed with BC were persistent with 
mammography screening in the five years prior to their BC diagnosis; the proportion which is 
higher than the proportion of elderly women who were regular users of mammography screening 
as reported in previous studies (Badgwell et al., 2008; McCarthy et al., 2000; Randolph et al., 
2002; Vyas et al., 2014).  Though the proportion of elderly WV women who were persistent with 
mammography screening is higher, the findings of the study should be interpreted with caution 
given the smaller sample size of the study cohort.   
Among those who were persistent with mammography screening, an overwhelming 89% 
of elderly WV women were diagnosed at early stages of BC.  In addition, elderly Appalachia-
WV women who were persistent with mammography screening were four times more likely to 
be diagnosed at early stages of BC, thereby indicating the beneficial effects of mammography 
screening in this elderly group which is inherently at higher risk of advanced and unstaged BC.  
The AOR in this study representing the impact of persistence with mammography screening on 
early stage BC is consistent though higher than those reported in the previous studies (Badgwell 
et al., 2008; McCarthy et al., 2000; Vyas et al., 2014).  This may be because of smaller sample 
size of the study which may have affected both AOR and wider confidence intervals.   
Even though current BC screening guidelines from US Preventive Services Task Force 
reported insufficient evidence for mammography screening for women above 74 years (Siu, & 
U.S. Preventive Services Task Force, 2016), our study findings demonstrated a higher likelihood 
of diagnosing BC at early stages for these elderly women who were persistent with 
mammography screening.  Our findings also suggest that among women age 80 and above, a 
higher proportion was not persistent with mammography screening, a finding consistent with a 
previous study (Badgwell et al., 2008).  Hence, efforts towards increasing awareness about 
regular mammography screening should be highly encouraged in the elderly women age 70 and 
above for whom there are no clear guidelines.  However, with increasing evidence of 
overdiagnosis of BC in these elderly women (van Ravesteyn et al., 2015), healthcare providers 
should also consider discussing the benefits and harms of mammography screening to make 
informed choices. 
Even though a higher proportion of the elderly Appalachia-WV women included in the 
analysis had lower income and education levels, had at least one comorbidity and resided in 
areas with no or just one BC screening center, there were no significant differences between the 
persistent users and non-persistent users except for the variable age.  In the multiple logistic 
regression model, only persistence with mammography screening was highly associated with 
early stages of BC thereby indicating that none of the included covariates had any negative 
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impact on persistence with mammography screening in the Appalachia-WV women diagnosed 
with BC.  Thus, these women were diagnosed at earlier stages when the treatments are usually 
less aggressive, and survival is significantly better.   
A major strength of this study is that the findings of this study help in understanding the 
benefits of persistence with mammography screening in elderly women age 70 and above in a 
rural setting such as WV, which has lower mammography screening rates than women in the age 
group 50-65 years of age (Khanna et al., 2009).  Utilization of the recently published algorithm 
with very high sensitivity and high predictive value to identify the screening mammograms from 
the Medicare claims files (Fenton et al., 2014) must also be considered a major strength of the 
study.  However, there are some limitations worth noting.  As this study utilized a cancer 
registry-Medicare linked database, certain patient characteristics such as annual household 
income, education level, access to BC screening centers at the patient level are not available, and 
hence census tract information for these variables were utilized which may provide 
overestimation of these variables.  However, census-tract information for these variables provide 
complimentary information on living circumstances and have been widely used in the 
epidemiological studies (Roux, Kiefe, Jacobs, Haan, & Jackson, 2001; Krieger, 1992).  Women 
who belonged to HMOs were excluded from the analyses as the use of physician services cannot 
be determined in Medicare beneficiaries enrolled in HMO plans, and thus mammography 
screening in women enrolled in these plans cannot be assessed.  Another limitation of the study 
is the smaller sample size which may affect the precision of the estimates.  In addition, certain 
unmeasured confounders such as severity of comorbidities, functional limitations, body mass 
index and views and attitudes towards mammography screening which may affect screening 
behavior were not accounted for in the analyses.  Overdiagnosis of breast cancer in these elderly 
women was not captured and accounted for in the study; however overdiagnosis can be precisely 
measured in a randomized controlled trial with a long follow-up period.  Lastly, the findings of 
the study are generalizable only to elderly Appalachia-WV women age 70 and above, and to 
other rural areas having similar characteristics as that of WV.  
 
CONCLUSION 
More than half of the elderly Appalachia-WV women with BC were persistent with 
mammography screening before their diagnosis.  Persistence with mammography screening is 
significantly associated with earlier stage at BC diagnosis in this rural and underserved 
population, which suggests targeting interventions to encourage regular mammography use in 
these women. 
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